Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 142.38 Million | USD 219.51 Million | 5.56% | 2022 |
FrequentlyAsked Questions
Phocomelia is a type of rare congenital disorder that is mainly characterized by the underdevelopment, absence, or malformation of limbs, particularly legs, and arms.
The global phocomelia market is projected to grow owing to the increasing advancements in medical technology especially in the fields of prosthetics and orthotics.
According to study, the global phocomelia market size was worth around USD 142.38 million in 2022 and is predicted to grow to around USD 219.51 million by 2030.
The CAGR value of the phocomelia market is expected to be around 5.56% during 2023-2030.
The global phocomelia market is projected to witness the highest growth in North America mainly due to the presence of a robust medical infrastructure and the successful conduct of several advanced or complex prosthetic surgeries in the US.
The global phocomelia market is led by players like Teva Pharmaceutical Industries Ltd., Smaart Pharmaceuticals, Tiefenbacher API + Ingredients GmbH & Co. KG, Cambrex Corporation, Hangzhou Jinlan Pharmaceutical Technology Development Co., Ltd., and Emcure Pharmaceuticals along with leading prosthetics makers such as Össur, Hanger Clinic, Ottobock, Fillauer LLC, WillowWood, Blatchford Group, Endolite, Freedom Innovations, College Park Industries, and Touch Bionics.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed